Cite
APA Citation
Peyrin-Biroulet, L., Rubin, D. T., Feagan, B., Oh, Y. S., Arulmani, U., Tyrrell, H., Maciuca, R., Williams, S., Tole, S., & Thommes, J. (n.d.). 20 ETROLIZUMAB IMPROVED ENDOSCOPIC SCORE, PATIENT-REPORTED OUTCOMES, AND INFLAMMATORY BIOMARKERS IN PATIENTS WITH MODERATE TO SEVERE UC WHO HAD FAILED TNF ANTAGONIST THERAPY: THE HICKORY OPEN-LABEL INDUCTION (OLI) COHORT. Inflammatory bowel diseases, 24, S12. http://access.bl.uk/ark:/81055/vdc_100095478398.0x000026